Transferring drug patent to a Tribe, is it right?
Last year Brent Saunders, the chief executive of Allergan, told that the company on the big price increase to generate profit has gotten out of hands. He the vowed that the company would not raise the price more than 10% in a year, and described patience assistance program that would ensure no one would [...]





